Page 5 - Topline News Today

Business expansion, investment in branding and experience centres, and improving supply chain helped the company achieve high growth in the fiscal year.

The energy of a young person, he was a child at heart. he believed anything is possible. he was saying, "if you give us the f—16jets, give "us western jets, we can fly them." there were a lot of people saying no, that will take years, and he said, "you dont know our pilots. "put us in the cockpit, we will master this in weeks." what did he think it would do in terms of the conflict? what did he think it would achieve? it was all about the range at which they could operate. the ukrainianjets ha...

Russian jets, far from the front lines because the russianjets, russian surface far from the front lines because the russian jets, russian surface to air missiles had a longer range, so it is like entering a gunfight with a pistol and the other guy has a rifle. you didnt stand a fair chance. they were using electronics in these aircraft that were 30 years old. the russians had topline stuff. even the aircraft thatjuice was flying the day he died, it was a 19605 flying the day he died, it was a 1...

Entain reported a big jump in the company's top line for the half driven by strong growth in the U.S..

Medacta Group SA Key word Sales Result Medacta Group SA 2023 HalfYear Unaudited TopLine Figures 28Jul2023 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely res

>> well, i mean, its interesting politically. i mean, what biodynamicsg tical, is essentially he inherited a growing economy from donald trump. s iswe were coming out of the pandemic, you know, in fits and starts, but coming outgrowin economy, everything was opening up. >> and then he spent a craploa d of money and then he helped cause inflation. he reappointed a fedhe chair tht kept the gas on with low interest rates and printing money and then you got what you have today, which is, yes, an eco...

Lanifibranor 800mg achieved the primary efficacy endpoint demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy (1H-MRS) following 24 weeks of treatment in patients

Topline data anticipated in Q4 2023 CUPERTINO, Calif., June 7, 2023 /PRNewswire/ -- DURECT Corporation , a biopharmaceutical company developing epigenetic therapies for the treatment of acute organ... | June 7, 2023

Study did not meet the primary endpointPamrevlumab was generally safe and well tolerated Topline results from LELANTOS-2 Phase 3 study of pamrevlumab in ambulatory patients with DMD expected 3Q 2023 ... | June 7, 2023

Topline results using the Companys SCI-110 met the trial’s primary and secondary end points, demonstrating high safety profile and reduced agitationTel-Aviv, June 02, 2023 -- SciSparc Ltd. ,... | June 2, 2023